[go: up one dir, main page]

PA8467301A1 - Nuevos derivados del acido dihidroxihexanoico - Google Patents

Nuevos derivados del acido dihidroxihexanoico

Info

Publication number
PA8467301A1
PA8467301A1 PA19998467301A PA8467301A PA8467301A1 PA 8467301 A1 PA8467301 A1 PA 8467301A1 PA 19998467301 A PA19998467301 A PA 19998467301A PA 8467301 A PA8467301 A PA 8467301A PA 8467301 A1 PA8467301 A1 PA 8467301A1
Authority
PA
Panama
Prior art keywords
acid
dihydroxyhexanic
new derivatives
derivatives
new
Prior art date
Application number
PA19998467301A
Other languages
English (en)
Inventor
John Charles Kath
Matthew Frank Brown
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8467301A1 publication Critical patent/PA8467301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)

Abstract

LOS DERIVADOS DEL ACIDO DIHIDROXIHEXANOICO DE LA FORMULA GENERAL SON UTILES PARA TRATAR LA INFLAMACION Y OTROS TRASTORNOS INMUNES.
PA19998467301A 1998-02-05 1999-01-18 Nuevos derivados del acido dihidroxihexanoico PA8467301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05

Publications (1)

Publication Number Publication Date
PA8467301A1 true PA8467301A1 (es) 2000-05-24

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998467301A PA8467301A1 (es) 1998-02-05 1999-01-18 Nuevos derivados del acido dihidroxihexanoico

Country Status (36)

Country Link
EP (1) EP1051405B1 (es)
JP (1) JP3693916B2 (es)
KR (1) KR100385529B1 (es)
CN (1) CN1177834C (es)
AP (1) AP992A (es)
AR (1) AR016175A1 (es)
AT (1) ATE337307T1 (es)
AU (1) AU752407B2 (es)
BG (1) BG104726A (es)
BR (1) BR9907655A (es)
CA (1) CA2320388C (es)
DE (1) DE69932920T2 (es)
DZ (1) DZ2717A1 (es)
EA (1) EA003137B1 (es)
ES (1) ES2268847T3 (es)
GT (1) GT199900011A (es)
HR (1) HRP20000529B1 (es)
HU (1) HUP0100832A3 (es)
IL (1) IL137330A0 (es)
IS (1) IS5562A (es)
MA (1) MA26603A1 (es)
MY (1) MY133125A (es)
NO (1) NO20003965D0 (es)
NZ (1) NZ505724A (es)
OA (1) OA11448A (es)
PA (1) PA8467301A1 (es)
PE (1) PE20000243A1 (es)
PL (1) PL342817A1 (es)
SK (1) SK11262000A3 (es)
TN (1) TNSN99013A1 (es)
TR (1) TR200002248T2 (es)
TW (1) TW470744B (es)
UA (1) UA57824C2 (es)
WO (1) WO1999040061A2 (es)
YU (1) YU47100A (es)
ZA (1) ZA99873B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2862300A (en) * 1999-01-29 2000-08-18 Millennium Pharmaceuticals, Inc. Methods for preventing graft rejection and ischemia-reperfusion injury
DE60039115D1 (de) * 1999-08-20 2008-07-17 Dow Agrosciences Llc Fungizide heterocyclische aromatische amide und deren zusammensetzungen, verfahren zu deren anwendung und herstellung
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
CZ20022542A3 (cs) 2000-02-04 2003-08-13 Pfizer Products Inc. Heterocyklické amidové deriváty
US6740636B2 (en) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
PT1404300E (pt) * 2001-06-22 2009-11-09 Bend Res Inc Composições farmacêuticas de dispersões de fármacos e polímeros neutros
KR100759635B1 (ko) 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
MXPA04007438A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
KR20050006256A (ko) 2002-05-14 2005-01-15 화이자 프로덕츠 인크. 디히드록시헥산산 유도체, 이들의 중간체, 및 제조 방법
BR0309932A (pt) * 2002-05-14 2005-02-09 Pfizer Prod Inc Métodos para a fabricação de derivados de diidro-furan-2-ona
AU2003250450A1 (en) * 2002-08-12 2004-02-25 Pfizer Products Inc. Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide
BR0313428A (pt) 2002-08-12 2005-06-28 Pfizer Prod Inc Composições farmacêuticas de drogas semi-ordenados e polìmeros
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
JP2007501218A (ja) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
ES2180600T3 (es) * 1994-10-19 2003-02-16 Novartis Ag Eteres de isosteros substrato de aspartato proteasa antivirales.
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
DZ2717A1 (fr) 2003-09-01
HUP0100832A2 (hu) 2002-02-28
CA2320388A1 (en) 1999-08-12
KR100385529B1 (ko) 2003-05-27
AP9901457A0 (en) 1999-03-31
UA57824C2 (uk) 2003-07-15
TNSN99013A1 (fr) 2005-11-10
MA26603A1 (fr) 2004-12-20
NO20003965D0 (no) 2000-08-04
HK1034969A1 (en) 2001-11-09
NZ505724A (en) 2003-02-28
ATE337307T1 (de) 2006-09-15
EP1051405A2 (en) 2000-11-15
OA11448A (en) 2003-11-18
YU47100A (sh) 2002-11-15
WO1999040061A2 (en) 1999-08-12
PL342817A1 (en) 2001-07-02
TW470744B (en) 2002-01-01
JP3693916B2 (ja) 2005-09-14
EA200000741A1 (ru) 2001-02-26
CN1177834C (zh) 2004-12-01
HUP0100832A3 (en) 2002-03-28
ZA99873B (en) 2000-08-04
AR016175A1 (es) 2001-06-20
EP1051405B1 (en) 2006-08-23
BG104726A (en) 2001-04-30
AU1778999A (en) 1999-08-23
HRP20000529A2 (en) 2001-08-31
DE69932920D1 (de) 2006-10-05
SK11262000A3 (sk) 2001-01-18
AU752407B2 (en) 2002-09-19
BR9907655A (pt) 2000-10-24
DE69932920T2 (de) 2007-02-08
NO20003965L (es) 2000-10-03
CN1290255A (zh) 2001-04-04
MY133125A (en) 2007-10-31
AP992A (en) 2001-08-06
WO1999040061A3 (en) 1999-10-21
PE20000243A1 (es) 2000-04-07
EA003137B1 (ru) 2003-02-27
CA2320388C (en) 2005-05-03
HRP20000529B1 (en) 2004-12-31
KR20010040684A (ko) 2001-05-15
ES2268847T3 (es) 2007-03-16
JP2002502839A (ja) 2002-01-29
IS5562A (is) 2000-07-14
TR200002248T2 (tr) 2000-12-21
GT199900011A (es) 2000-07-20
IL137330A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
PA8467301A1 (es) Nuevos derivados del acido dihidroxihexanoico
HN1998000035A (es) Nuevos derivados del acido hexanoico
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
CU23029A3 (es) Analogos sustituidos del benzopirano para el tratamiento de la inflamacion
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
UY26058A1 (es) Compuestos utiles como antiinflamatorios ley 17.164 art. 127
AR023777A1 (es) Nuevos compuestos
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
ES2150808T3 (es) Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
ATE386742T1 (de) Imidazonaphthyridine
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
DE69823493D1 (de) Tetrahydropyridoverbindungen
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ECSP003590A (es) Compuestos calcioliticos
ES2164765T3 (es) Heterociclilbenzonitrilos.
ES2052391T3 (es) Derivados de acido 5-aminosalicilico para la terapia de enfermedades inflamatorias cronicas del intestino.
ECSP992841A (es) Nuevos derivados del acido dihidroxihexanoico
MX9602407A (es) Composiciones farmaceuticas.
IT1258788B (it) Derivati solforati di acidi biliari